Immuneering to Participate in the Cowen 44th Annual Health Care Conference
04 mars 2024 08h00 HE
|
Immuneering Corporation
CAMBRIDGE, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for...
uniQure to Participate in Multiple Upcoming Industry Conferences in March
02 mars 2023 07h05 HE
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, March 02, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
Evelo Biosciences to Participate in the Cowen 43rd Annual Health Care Conference
01 mars 2023 06h00 HE
|
Evelo Biosciences, Inc.
CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered anti-inflammatory...
Surface Oncology to Participate in the Cowen 43rd Annual Health Care Conference
28 févr. 2023 16h15 HE
|
Surface Oncology, Inc.
CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Icosavax to Participate in the Upcoming Healthcare Conferences
28 févr. 2023 08h00 HE
|
Icosavax, Inc.
SEATTLE, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
Exagen Inc. to Participate in Upcoming March Conferences
27 févr. 2023 09h00 HE
|
Exagen Inc.
SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following March...
Esperion to Participate in the Cowen 43rd Annual Healthcare Conference
23 févr. 2023 08h00 HE
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that Sheldon Koenig, president and chief executive officer, will present at Cowen’s 43rd annual Health...
Solid Power to Present at Cowen 15th Annual Global Transportation & Sustainable Mobility Conference
01 sept. 2022 08h00 HE
|
Solid Power, Inc.
LOUISVILLE, Colo., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Solid Power, Inc. (“Solid Power”) (Nasdaq: SLDP), an industry-leading developer of all-solid-state battery cells for electric vehicles, today...
Revolution Medicines to Participate in Cowen 42nd Annual Health Care Conference
01 mars 2022 16h05 HE
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers,...
Esperion to Participate in Upcoming Virtual Cowen 42nd Annual Healthcare Conference
24 févr. 2022 08h00 HE
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that Chief Medical Officer, Dr. JoAnne Foody, will participate in a Cardiometabolic/NASH focused panel, in...